IMC-KRAS-G12D

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameIMC-KRAS-G12D
Drug Alias NameIMC-KRAS-G12DIMC-KRAS-G-12-D
ClassificationBiologics > T cell engagers
Mechanisms of ActionKRAS G12D inhibitors
TargetsKRAS G12D
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesImmunocore Ltd
China Registration ClassN/A

Develop Information

Active CompaniesImmunocore Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A